KRS Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$445K |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$443K |
| 3 |
ON Semiconductor
ON
|
+$420K |
| 4 |
Marvell Technology
MRVL
|
+$366K |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$339K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree International AI Enhanced Value Fund
AIVI
|
+$6.09M |
| 2 |
AVLR
Avalara, Inc.
AVLR
|
+$324K |
| 3 |
Unity
U
|
+$277K |
| 4 |
Lumentum
LITE
|
+$272K |
| 5 |
Airbnb
ABNB
|
+$269K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.72% |
| 2 | Healthcare | 18.69% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Financials | 8.36% |
| 5 | Industrials | 5.83% |
Similar funds
KRS Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, KRS Capital Management held 110 positions worth $73.1M, up 0.83% from $72.5M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
KRS Capital Management withdrew a net $2.6M in Q4 2022, closing 6 positions and reducing 24 holdings. Its most notable exit was WisdomTree International AI Enhanced Value Fund, an estimated $6.09M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, KRS Capital Management opened a new position in Merck worth $483K.
- KRS Capital Management's largest Q4 2022 buy was Merck: 4,352 shares worth $483K.
- KRS Capital Management added most to Eli Lilly in Q4 2022, an estimated $104K increase.
- KRS Capital Management's biggest Q4 2022 reduction was Apple, cutting an estimated $146K.
- KRS Capital Management fully exited WisdomTree International AI Enhanced Value Fund in Q4 2022, selling an estimated $6.09M.
- KRS Capital Management's ten largest holdings make up 36% of its $73.1M portfolio in Q4 2022.
- KRS Capital Management opened 15 new positions and closed 6 in Q4 2022.
- KRS Capital Management's portfolio value rose 0.83% quarter-over-quarter to $73.1M.
Based on KRS Capital Management's 13F filing for Q4 2022, filed 19 Jan 2023.